About 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile
4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile (PubChem CID 88561382) has the molecular formula C25H31N5O2S
and a molecular weight of 465.62 g/mol. Its IUPAC name is 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile.
Molecular Properties
| Compound Name | 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile |
| PubChem CID | 88561382 |
| Molecular Formula | C25H31N5O2S |
| Molecular Weight | 465.62 g/mol |
| Exact Mass | 465.22 |
| IUPAC Name | 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile |
| SMILES | Cc1cc(N2C(=O)C(C)(C)N(CCCOc3ccc(CNC(C)C)nc3)C2=S)ccc1C#N |
| InChI | InChI=1S/C25H31N5O2S/c1-17(2)27-15-20-8-10-22(16-28-20)32-12-6-11-29-24(33)30(23(31)25(29,4)5)21-9-7-19(14-26)18(3)13-21/h7-10,13,16-17,27H,6,11-12,15H2,1-5H3 |
| InChIKey | OLRFVMVLFVQKET-UHFFFAOYSA-N |
| XLogP | 3.94 |
| TPSA | 81.49 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 465.62 |
| LogP ≤ 5 | 3.94 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'} |
|---|
Analyze 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile?
The IUPAC name of 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile (CID 88561382) is 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile.
What is the SMILES notation for 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile?
The canonical SMILES for 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile is Cc1cc(N2C(=O)C(C)(C)N(CCCOc3ccc(CNC(C)C)nc3)C2=S)ccc1C#N.
What is the InChIKey of 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile?
The InChIKey is OLRFVMVLFVQKET-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H31N5O2S/c1-17(2)27-15-20-8-10-22(16-28-20)32-12-6-11-29-24(33)30(23(31)25(29,4)5)21-9-7-19(14-26)18(3)13-21/h7-10,13,16-17,27H,6,11-12,15H2,1-5H3.
What are the key properties of 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile?
4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile has a molecular weight of 465.62 g/mol, XLogP of 3.94, 9 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4,4-dimethyl-5-oxo-3-[3-[[6-[(propan-2-ylamino)methyl]-3-pyridinyl]oxy]propyl]-2-sulfanylideneimidazolidin-1-yl]-2-methylbenzonitrile is sourced from PubChem (CID 88561382), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).